# PR #96 Targeted Merge Authorization Re-Review v0.1

> Target PR: #96
> Reviewed exact head: `f1031355c84981a271ec9c4da214a83faf3506cc`
> Reviewed base: `ab2847af24c16909990140d134854d2da7f57d8f`

## Result

```text
BF-PR96-MAR-01 = CLOSED
BF-PR96-MAR-02 = CLOSED

PR #96 Targeted Merge Authorization Re-Review
= PASS

PR #96
= ELIGIBLE_FOR_EXPLICIT_REPOSITORY_OWNER_MERGE_AUTHORIZATION

Proposed authorization
= AUTH-PR96-U03-U04-AGGREGATE-MERGE-001

Permitted target
= impl/u03-cd08-postimplementation-clinical-validation

Permitted source exact head
= f1031355c84981a271ec9c4da214a83faf3506cc

Permitted method
= STANDARD_MERGE_COMMIT_ONLY

Merge Authorization
= NOT_GRANTED_BY_THIS_REVIEW
```

The remediation delta was limited to two current U03 status-index files.

No runtime, test, workflow, U03 clinical-truth, U04 RDP, routing, or production semantic drift was introduced.

Historical BF0304 authorization/readiness/verification records remain chronology.

Hard boundaries remain unchanged:

```text
U04 Live Routing Activation = NOT_AUTHORIZED
Clinical Runtime Production = NOT_ENABLED
Production Authorization = BLOCKED
Real-patient traffic = NOT_AUTHORIZED
Main Integration = NOT_COMPLETE
```
